PTH and Osteopenia: Histomorphometric and micro-CT evaluations for the contralateral tibiae demonstrated that continuous PTH1–34 infusion for two weeks caused osteopenia, and intermittent administration increased the bone mass, although bone formation and resorption were enhanced in both PTH-treated groups (Supplemental Tables 1 and 2).